as on February 17, 2026 at 9:31 pm IST
Day's Low
Day's High
6.75%
Downside
14.68%
Upside
52 Week's Low
52 Week's High
27.38%
Downside
108.73%
Upside
as on February 17, 2026 at 4:01 pm IST
Market Cap
₹20.23 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-10.68
Return on capital employed (ROCE)
0Industry PE ratio
47.9
Beta (LTM)
0.13
P/B Ratio
-3.35
Dividend Yield
0PEG Ratio
48.55
Quarterly Earnings Growth YOY
311.11
EPS (TTM)
-0.09
Sector
Healthcare
Book Value
1.32
Technical Analysis
Bearish
View Technical Analysis
as on February 17, 2026 at 4:01 pm IST
Transgene Biotek in the last 5 years
Lowest (-227.67x)
December 31, 2024
Today (-10.68x)
February 16, 2026
Industry (47.90x)
February 16, 2026
Highest (13.23x)
October 8, 2018
Today’s Price to Earnings Ratio: -10.68x
Compare market cap, revenue, PE, and other key metrics of Transgene Biotek with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 20.23 | -6.38% | 0.96 | -1 | NA | |
| NA | 1,530.90 | 4248.94% | 0.00 | 18 | 147 | |
| NA | 46.10 | 47.12% | 0.00 | 5 | 16 | |
| NA | 25.87 | -7.1% | 0.00 | -1 | 9 | |
| NA | 690.56 | -3.46% | 0.50 | 37 | 3 |
Get share price movements and forecasts by analysts on Transgene Biotek.
Source: S&P Global Market Intelligence
Search interest for Transgene Biotek Ltd Stock has increased by 67% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:67% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Transgene Biotek.
Transgene Biotek Ltd’s net profit fell -311.11% since last year same period to ₹0.37Cr in the Q3 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated 5.13% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -0.71 Cr → -0.37 Cr (in ₹), with an average increase of 26.9% per quarter
Price Rise
![]()
In the last 7 days, Transgene Biotek stock has moved up by 26.5%
Against Peers
![]()
In the last 1 year, Take Solutions Ltd has given 355.0% return, outperforming this stock by 391.4%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 21.68% of holdings in Dec 2025 quarter
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 70.04% of holdings in Dec 2025 quarter
Against Peers
![]()
In the last 3 years, Vimta Labs Ltd has given 200.7% return, outperforming this stock by 202.2%
Revenue Fall
![]()
Revenue is down for the last 4 quarters, 0.12 Cr → 0.05 Cr (in ₹), with an average decrease of 19.4% per quarter
| Organisation | Transgene Biotek Ltd |
| Industry | Healthcare |
| CEO | K Koteswara Rao |
| E-voting on shares | Click here to vote |
Transgene Biotek share price today stands at ₹2.52 as on at the close of the market. Transgene Biotek share today touched a day high of ₹2.89 and a low of ₹2.35.
Transgene Biotek touched a 52 week high of ₹5.26 and a 52 week low of ₹1.83. Transgene Biotek share price today i.e. is closed at ₹2.52, which is -52.09% down from its 52 week high and 37.70% up from its 52 week low.
Transgene Biotek market capitalisation is ₹20.23 Cr as on .
To buy Transgene Biotek shares, you need to follow these steps:
Transgene Biotek trading volume is 74.32K as on . This means that 74.32K shares of Transgene Biotek were bought and sold on the stock market during today's trading session.